These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2933804)
1. Percutaneous transluminal renal artery dilatation for fibromuscular dysplasia with special reference to the acute effects on the renin-angiotensin-aldosterone system and blood pressure. Hägg A; Lörelius LE; Mörlin C; Aberg H Scand J Urol Nephrol; 1985; 19(3):205-9. PubMed ID: 2933804 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous transluminal renal artery dilatation for fibromuscular dysplasia with special reference to the acute effects on the renin-angiotensin-aldosterone-system and blood pressure. Hägg A; Lörelius LE; Mörlin C; Aberg H Acta Med Scand Suppl; 1985; 693():93-6. PubMed ID: 3158170 [No Abstract] [Full Text] [Related]
3. Orthostatic hypertension due to coexistence of renal fibromuscular dysplasia and nephroptosis. Tsukamoto Y; Komuro Y; Akutsu F; Fujii K; Marumo F; Kusano S; Kikawada R Jpn Circ J; 1988 Dec; 52(12):1408-14. PubMed ID: 2977192 [TBL] [Abstract][Full Text] [Related]
4. Serial measurements of plasma renin activity, aldosterone and cortisol during percutaneous transluminal angioplasty of the renal artery in man. Hägg A; Lörelius LE; Mörlin C; Wide L Acta Physiol Scand; 1988 Dec; 134(4):473-8. PubMed ID: 2977883 [TBL] [Abstract][Full Text] [Related]
5. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Airoldi F; Palatresi S; Marana I; Bencini C; Benti R; Lovaria A; Alberti C; Nador B; Nicolini A; Longari V; Gerundini P; Morganti A Am J Hypertens; 2000 Nov; 13(11):1210-7. PubMed ID: 11078182 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study. Yang YK; Zhang Y; Meng X; Yang KQ; Jiang XJ; Wu HY; Zhang HM; Song L; Wang LP; Gao LG; Zhou XL Clin Res Cardiol; 2016 Nov; 105(11):930-937. PubMed ID: 27270759 [TBL] [Abstract][Full Text] [Related]
7. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. Cadour F; Silhol F; Iline N; Giorgi R; Lorthioir A; Amar L; Sapoval M; Rousseau H; Sarlon G; Thony F; Jacquier A J Vasc Surg; 2022 Mar; 75(3):939-949.e1. PubMed ID: 34601043 [TBL] [Abstract][Full Text] [Related]
8. Patency of percutaneous transluminal renal angioplasty: a prospective sonographic study. Baumgartner I; Triller J; Mahler F Kidney Int; 1997 Mar; 51(3):798-803. PubMed ID: 9067913 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results. Kim HJ; Do YS; Shin SW; Park KB; Cho SK; Choe YH; Choo SW; Choo IW; Kim DK Korean J Radiol; 2008; 9(1):38-44. PubMed ID: 18253074 [TBL] [Abstract][Full Text] [Related]
10. Fibromuscular dysplasia of the renal artery--management and outcome. Hägg A; Aberg H; Eriksson I; Lörelius LE; Mörlin C Acta Chir Scand; 1987 Jan; 153(1):15-20. PubMed ID: 2953159 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Tegtmeyer CJ; Elson J; Glass TA; Ayers CR; Chevalier RL; Wellons HA; Studdard WE Radiology; 1982 Jun; 143(3):631-7. PubMed ID: 6210930 [TBL] [Abstract][Full Text] [Related]
14. Renal angioplasty for hypertension: predictive factors for long-term success. Martin EC; Mattern RF; Baer L; Fankuchen EI; Casarella WJ AJR Am J Roentgenol; 1981 Nov; 137(5):921-4. PubMed ID: 6457523 [TBL] [Abstract][Full Text] [Related]
15. A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery. Sakuma I; Saito J; Matsuzawa Y; Omura M; Matsui S; Nishikawa T Intern Med; 2018 Sep; 57(18):2689-2694. PubMed ID: 29709926 [TBL] [Abstract][Full Text] [Related]
17. The long term effects of percutaneous transluminal angioplasty for treating patients with renovascular hypertension: case studies. Ohta H; Takabatake T; Yamamoto Y; Ishida Y; Hara H; Ushiogi Y; Nakamura S; Kawabata M; Hashimoto N; Sasaki T Angiology; 1986 Jul; 37(7):535-42. PubMed ID: 2942063 [TBL] [Abstract][Full Text] [Related]
18. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Birrer M; Do DD; Mahler F; Triller J; Baumgartner I Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):146-52. PubMed ID: 11863332 [TBL] [Abstract][Full Text] [Related]
19. [Results of percutaneous transluminal angioplasty in renal artery stenosis during the period 1978-1986]. Puijlaert CB; Klinge J; Mali WP; Geyskes GG; Kouwenberg JJ Ned Tijdschr Geneeskd; 1989 Feb; 133(8):400-4. PubMed ID: 2522595 [TBL] [Abstract][Full Text] [Related]
20. Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction. Takamiya Y; Okamura K; Shirai K; Urata H Am J Case Rep; 2019 Nov; 20():1684-1690. PubMed ID: 31732710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]